Peter W. Hunt

Peter W. Hunt's AcademicInfluence.com Rankings

Peter W. Hunt

Biology

#12957

World Rank

#16468

Historical Rank

Genetics

#1426

World Rank

#1528

Historical Rank

biology Degrees

Download Badge

Biology

Peter W. Hunt's Degrees

PhD Genetics Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Peter W. Hunt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter W. Hunt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation (2010) (1129)
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection (2013) (958)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. (2003) (840)
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. (2004) (836)
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. (2008) (653)
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. (2009) (592)
Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism (2013) (550)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies (2013) (537)
Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease (2010) (503)
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality (2014) (484)
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. (2014) (457)
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. (2014) (404)
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis (2009) (374)
HIV and Inflammation: Mechanisms and Consequences (2012) (339)
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. (2013) (319)
Differential microRNA regulation of HLA-C expression and its association with HIV control (2011) (319)
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. (2011) (314)
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. (2009) (306)
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. (2013) (298)
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. (2016) (284)
Residual immune dysregulation syndrome in treated HIV infection. (2013) (281)
Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. (2012) (276)
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy (2003) (273)
T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women (2011) (273)
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses (2006) (261)
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time (2013) (252)
Immunologic basis of cardiovascular disease in HIV-infected adults. (2012) (248)
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. (2009) (238)
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy (2011) (217)
Real-Time Adherence Monitoring for HIV Antiretroviral Therapy (2010) (213)
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. (2013) (211)
Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy (2008) (209)
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. (2011) (197)
Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease (2010) (191)
Impact of HIV Infection on Diastolic Function and Left Ventricular Mass (2010) (173)
Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting (2012) (167)
Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses (2006) (166)
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients (2009) (166)
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection. (2016) (164)
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. (2006) (159)
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. (2011) (158)
Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda (2014) (150)
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients (2011) (149)
Gut epithelial barrier and systemic inflammation during chronic HIV infection (2015) (147)
Internalized Stigma, Social Distance, and Disclosure of HIV Seropositivity in Rural Uganda (2013) (147)
A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers (2011) (140)
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy. (2015) (133)
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. (2013) (132)
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia (2004) (127)
HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy (2009) (122)
T cell activation predicts carotid artery stiffness among HIV-infected women. (2011) (116)
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. (2013) (112)
CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection. (2016) (112)
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. (2012) (111)
Increased Frequency of Regulatory T Cells Accompanies Increased Immune Activation in Rectal Mucosae of HIV-Positive Noncontrollers (2011) (106)
Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers (2013) (105)
HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses (2010) (104)
The Dynamic Relationship Between Social Support and HIV-Related Stigma in Rural Uganda (2014) (100)
The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. (2014) (99)
Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease (2013) (96)
Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation (2012) (96)
GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda (2013) (93)
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. (2020) (91)
AIDS Alters the Commensal Plasma Virome (2013) (90)
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. (2021) (90)
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease (2014) (89)
Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging (2014) (87)
Disease drivers of aging (2016) (84)
Comparison of Self-Reported Alcohol Consumption to Phosphatidylethanol Measurement among HIV-Infected Patients Initiating Antiretroviral Treatment in Southwestern Uganda (2014) (83)
How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda (2013) (81)
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. (2016) (78)
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals (2010) (77)
Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals (2014) (76)
A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis (2012) (75)
Th17, gut, and HIV: therapeutic implications (2010) (74)
Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. (2006) (73)
Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers (2010) (72)
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes (2013) (71)
Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction (2017) (71)
Reversal of the Kynurenine Pathway of Tryptophan Catabolism May Improve Depression in ART-Treated HIV-Infected Ugandans (2014) (70)
Role of immune activation in HIV pathogenesis (2007) (69)
Realtime adherence monitoring of antiretroviral therapy among hiv-infected adults and children in rural uganda (2013) (66)
Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda (2013) (66)
Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion (2015) (65)
Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death. (2013) (65)
Evidence for the Reliability and Validity of the Internalized AIDS-Related Stigma Scale in Rural Uganda (2012) (63)
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. (2016) (63)
Antiretroviral Treatment Effect on Immune Activation Reduces Cerebrospinal Fluid HIV-1 Infection (2008) (63)
Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy–Treated Human Immunodeficiency Virus–Infected Individuals (2018) (63)
Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency (2018) (63)
Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda (2015) (62)
A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients. (2013) (61)
Altered distribution of mucosal NK cells during HIV infection (2011) (60)
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells (2014) (59)
The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial (2014) (56)
Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. (2011) (56)
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy (2017) (56)
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. (2014) (56)
Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United States (2017) (55)
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus–Infected Individuals Receiving Suppressive Antiretroviral Therapy (2017) (55)
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection (2013) (54)
Impact of early cART in the gut during acute HIV infection. (2016) (54)
Sexual Relationship Power and Depression among HIV-Infected Women in Rural Uganda (2012) (52)
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers (2013) (52)
Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals (2017) (51)
The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection (2014) (51)
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009 (2011) (51)
Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda (2014) (50)
Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir (2020) (50)
Higher Baseline CD4 Cell Count Predicts Treatment Interruptions and Persistent Viremia in Patients Initiating ARVs in Rural Uganda (2013) (49)
Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor (2015) (49)
Role of immune activation in progression to AIDS (2016) (49)
Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. (2015) (49)
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells (2019) (47)
Changes in Food Insecurity, Nutritional Status, and Physical Health Status After Antiretroviral Therapy Initiation in Rural Uganda (2012) (47)
HIV and aging: emerging research issues. (2014) (47)
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen. (2007) (47)
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. (2014) (46)
Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda (2015) (45)
Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States. (2015) (44)
The independent effect of drug resistance on T cell activation in HIV infection (2006) (43)
Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection (2016) (41)
Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy (2019) (40)
CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients (2016) (40)
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection (2018) (40)
Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers. (2010) (39)
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies. (2012) (38)
HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. (2011) (38)
Prospective Study of the Mental Health Consequences of Sexual Violence Among Women Living With HIV in Rural Uganda (2016) (38)
Detection of HIV-1-Specific Gastrointestinal Tissue Resident CD8+ T-cells in Chronic Infection (2017) (36)
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection (2019) (36)
Increased Systemic Inflammation and Gut Permeability Among Women With Treated HIV Infection in Rural Uganda (2018) (36)
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda. (2014) (35)
Optimizing Network Connectivity for Mobile Health Technologies in sub-Saharan Africa (2012) (33)
Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection (2018) (32)
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. (2012) (31)
Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. (2016) (31)
Natural control of HIV-1 replication and long-term nonprogression: overlapping but distinct phenotypes. (2009) (31)
Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration (2014) (31)
The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART (2011) (30)
Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring (2017) (30)
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression (2017) (29)
Factors Associated With CD8+ T-Cell Activation in HIV-1–Infected Patients on Long-term Antiretroviral Therapy (2014) (29)
p16INK4a Expression and Immunologic Aging in Chronic HIV Infection (2016) (29)
Point-of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIV (2014) (28)
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity (2020) (28)
Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection (2018) (28)
Predominance of Weakly Cytotoxic, T-betLowEomesNeg CD8+ T-cells in Human Gastrointestinal Mucosa: Implications for HIV Infection (2016) (28)
Discordance Between Peripheral and Colonic Markers of Inflammation During Suppressive ART (2014) (27)
Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop (2020) (27)
CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda (2014) (26)
Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy (2017) (26)
Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy (2018) (25)
HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods (2013) (25)
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells (2022) (25)
HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods (2016) (25)
CD8+ T-Cell Activation in HIV-1–Infected Patients Experiencing Transient Low-level Viremia During Antiretroviral Therapy (2013) (23)
Human Herpesvirus Replication and Abnormal CD8+ T Cell Activation and Low CD4+ T Cell Counts in Antiretroviral-Suppressed HIV-Infected Patients (2009) (23)
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy (2018) (23)
Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation (2010) (23)
The Factor Structure and Presentation of Depression Among HIV-Positive Adults in Uganda (2014) (23)
Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome. (2015) (23)
Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection (2018) (22)
Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda (2018) (22)
HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda (2016) (22)
An Optimized and Validated Method for Isolation and Characterization of Lymphocytes from HIV+ Human Gut Biopsies. (2017) (21)
Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence (2014) (21)
Immune-based therapy for HIV infection: are acute and chronic HIV infection different diseases? (2006) (21)
Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression (2018) (21)
HIV persistence and T-cell activation in blood, rectal and lymph node tissue in HIV-infected individuals receiving suppressive ART. (2017) (21)
Dissemination of Research Findings to Research Participants Living with HIV in Rural Uganda: Challenges and Rewards (2013) (21)
Host genetic determinants of HIV pathogenesis: an immunologic perspective (2008) (21)
The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. (2015) (20)
Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment (2013) (20)
"Food Insecurity is Associated with Morbidity and Patterns of Healthcare Utilization among HIV-Infected Individuals in Rural Uganda." (2012) (20)
Infection With Different HIV Subtypes Is Associated With CD4 Activation-Associated Dysfunction and Apoptosis (2009) (20)
Relationship Power and Sexual Violence Among HIV-Positive Women in Rural Uganda (2016) (20)
Disinhibition in Risky Sexual Behavior in Men, but Not Women, during Four Years of Antiretroviral Therapy in Rural, Southwestern Uganda (2013) (20)
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART (2021) (19)
Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ (2018) (19)
Physical Activity Intensity is Associated with Symptom Distress in the CNICS Cohort (2018) (19)
Comparative Effectiveness of Fish Oil Versus Fenofibrate, Gemfibrozil, and Atorvastatin on Lowering Triglyceride Levels Among HIV-Infected Patients in Routine Clinical Care (2013) (19)
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults with HIV. (2021) (19)
Immunologic profiles distinguish aviremic HIV-infected adults (2016) (18)
Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS) (2019) (18)
Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure (2017) (18)
Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression. (2017) (18)
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. (2020) (18)
D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda (2016) (17)
Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches (2017) (17)
Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites (2019) (17)
Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda (2018) (16)
Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda (2014) (16)
Unhealthy Alcohol Use is Associated with Monocyte Activation Prior to Starting Antiretroviral Therapy. (2015) (16)
Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda. (2011) (15)
Can Biomarkers Advance HIV Research and Care in the Antiretroviral Therapy Era? (2018) (15)
Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection (2012) (15)
Sexual Relationship Power and Malnutrition Among HIV-Positive Women in Rural Uganda (2012) (15)
Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda (2018) (15)
Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda (2017) (15)
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy (2013) (15)
Tobacco Use Among Adults Initiating Treatment for HIV Infection in Rural Uganda (2014) (14)
Declining Prevalence of Probable Depression Among Patients Presenting for Antiretroviral Therapy in Rural Uganda: The Role of Early Treatment Initiation (2014) (14)
Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda (2018) (14)
Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. (2013) (14)
Corrigendum: Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection (2017) (14)
Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5 (2020) (13)
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection (2022) (13)
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans (2016) (13)
Erratum: Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection (Journal of Infectious Diseases (2009) 199 (1177-85)) (2009) (12)
Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay. (2020) (12)
Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women (2011) (12)
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity (2018) (12)
Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy (2014) (12)
Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity (2019) (12)
No Association Found Between Traditional Healer Use and Delayed Antiretroviral Initiation in Rural Uganda (2011) (12)
A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function (2018) (11)
CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa (2015) (11)
Soluble CD163 and Clinical Outcomes in Treated HIV Infection: Insights Into Mechanisms. (2016) (11)
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus (2020) (11)
Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction (2019) (11)
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection (2022) (11)
Cooking fuel and respiratory symptoms among people living with HIV in rural Uganda (2017) (11)
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV‐Infected Adults (2019) (11)
Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005‐2013 (2018) (11)
Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March–December 2020 (2022) (11)
Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. (2022) (10)
Kynurenine 3-Monooxygenase Inhibition during Acute Simian Immunodeficiency Virus Infection Lowers PD-1 Expression and Improves Post–Combination Antiretroviral Therapy CD4+ T Cell Counts and Body Weight (2019) (10)
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers (2013) (10)
A Hidden Menace? Cytomegalovirus Infection is Associated with Reduced Cortical Gray Matter Volume in Major Depressive Disorder (2020) (10)
Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorder (2021) (10)
A Randomized Pilot Study Comparing Combination Therapy plus Enfuvirtide versus a Treatment Interruption followed by Combination Therapy plus Enfuvirtide (2005) (10)
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents. (2020) (10)
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. (2016) (10)
The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa (2015) (10)
CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals (2019) (9)
Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV (2021) (9)
Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection. (2019) (9)
Genetic architecture of cardiometabolic risks in people living with HIV (2020) (9)
Very Early ART and Persistent Inflammation in Treated HIV. (2017) (9)
Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection. (2022) (8)
HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia (2019) (8)
Higher CD27+CD8+ T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4+ T Cell Recovery in Treated HIV Infection (2013) (8)
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals (2017) (8)
Association of Age-related Macular Degeneration With Mortality in Patients With Acquired Immunodeficiency Syndrome; Role of Systemic Inflammation. (2019) (8)
HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives (2021) (8)
Markers of immune activation and inflammation in individuals with post-acute sequelae of SARS-CoV-2 infection (2021) (8)
Oral abstracts of the 21st International AIDS Conference (2017) (8)
Participating in HIV Cure Research at the End of Life. (2019) (8)
Super learner analysis of real‐time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non‐differentiated care approaches for persons living with HIV in rural Uganda (2020) (8)
Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression. (2019) (7)
Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study (2021) (7)
INFLAMMATION IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION AMONG INDIVIDUALS WITH TREATED AND SUPPRESSED HIV INFECTION (2010) (7)
Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events. (2020) (7)
Contraceptive use following unintended pregnancy among Ugandan women living with HIV (2018) (7)
Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study (2019) (7)
Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC) (2021) (7)
Pneumoproteins are associated with pulmonary function in HIV-infected persons (2019) (6)
All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection. (2018) (6)
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes (2020) (6)
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID (2022) (6)
Circulating CD30+ CD4+ T Cells Increase Prior to HIV Rebound Following Analytical Antiretroviral Treatment Interruption. (2020) (6)
Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS (2019) (6)
Some But Not All Biomarkers of Immune Activation Remain Abnormal Despite Very Early Treatment of HIV. (2020) (6)
Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response. (2021) (6)
High incidence of intended partner pregnancy among men living with HIV in rural Uganda: Implications for safer conception services. (2019) (6)
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda (2021) (5)
Association of Gut Intestinal Integrity and Inflammation with Insulin Resistance in Adults Living with HIV in Uganda. (2019) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Association between bilirubin, atazanavir, and cardiovascular disease events among people living with HIV across the US. (2019) (5)
TCF-1 regulates the stem-like memory potential of HIV-specific CD8+ T cells in elite controllers (2020) (5)
CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. (2018) (5)
Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome (2018) (4)
Immunoglobulin E (IgE) Levels are associated with Kaposi's Sarcoma in HIV-Infected African Adults. (2020) (4)
Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV (2017) (4)
Association of Infection with Chronic Hepatitis C Virus and Myocardial Infarction in People Living with HIV in the United States. (2019) (4)
A closer look at hepatitis C clearance in HIV controllers: a response. (2014) (4)
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. (2015) (4)
Plasma CD16+ Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV+ Adults on Combination Antiretroviral Therapy (2022) (4)
Response: Maraviroc intensification and microbial translocation. (2013) (4)
Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the CNICS cohort. (2020) (4)
Inflammation Investigated as a Source of Pharmacokinetic Variability of Atazanavir in AIDS Clinical Trials Group Protocol A5224s (2018) (4)
Antiretroviral treatment of acute HIV infection normalizes CSF markers of CNS inflammation. A consequence of reduced CNS reservoir? (2019) (4)
Evidence of recent Epstein-Barr virus reactivation in individuals experiencing Long COVID (2022) (3)
Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda (2017) (3)
Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection (2021) (3)
Characterization of persistent HIV-1 in a broad spectrum of CD4+T cells isolated from peripheral blood and gut associated lymphoid tissue from patients on long-term suppressive therapy (2012) (3)
HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study. (2018) (3)
Participating in Human Immunodeficiency Virus Cure Research at the End of Life (2019) (3)
NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research. (2021) (3)
Second European Round Table on the Future Management of HIV (2015) (3)
High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia. (2016) (3)
Microbiome and Metabolome driven differentiation of TGF-β producing Tregs leads to Senescence and HIV latency (2020) (3)
Antiretroviral therapy: stubborn limitations persist (2014) (3)
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV (2009) (3)
Microbiome And Metabolome Driven Differentiation Of TGF-β Producing Tregs Leads to Senescence and HIV Latency (2021) (3)
The Clinical-Translational Physician-Scientist: Translating Bedside to Bench. (2018) (3)
Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study (2020) (2)
Chronic viral coinfections differentially affect the likelihood of developing long COVID (2023) (2)
Correction: Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda (2013) (2)
Title Ability of HIV-1 Nef to downregulate CD 4 and HLA class I differs among viral subtypes Permalink (2013) (2)
Reply to Shulman et al. (2007) (2)
Some Aspects of CD8+ T Cell Exhaustion are Associated with Altered T Cell Mitochondrial Features and ROS content in HIV Infection. (2019) (2)
IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health (2022) (2)
Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection (2017) (2)
Association between cytomegalovirus infection, reduced gray matter volume, and resting-state functional hypoconnectivity in major depressive disorder: a replication and extension (2021) (2)
Internalized stigma, depressive symptoms, and the modifying role of antiretroviral therapy: A cohort study in rural Uganda (2021) (2)
Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda (2016) (2)
Hematologic, Hepatic, Renal, and Lipid Laboratory Monitoring After Initiation of Combination Antiretroviral Therapy in the United States, 2000–2010 (2013) (2)
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US (2021) (2)
Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes. (2021) (2)
Host Variation in Interferon, MHC Class I, Glycosylation, and Viral Transcription Genes Predict HIV Persistence (2021) (2)
Bending the curve: maximising impact with focused HIV prevention (2014) (1)
Cell death bypyroptosis drives CD 4 T-cell depletion in HIV-1 infection (2013) (1)
Characterising ‘exceptional’ control among HIV elite controllers (2019) (1)
Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa? (2017) (1)
The Atlas of the In Vivo HIV CD4 T Cell Reservoir (2020) (1)
Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection (2021) (1)
Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors. (2018) (1)
Progression of Platelet Counts in Treatment Naïve HIV/HCV Co-Infection * (2013) (1)
Reply to Barrett, et al. (2016) (1)
Potential inflammatory consequences in HIV controllers (2010) (1)
Single cell analysis of in vivo HIV reservoir uncovers novel markers of latent cells (2019) (1)
Effective Contraceptive Use Following Unplanned Pregnancy Among Ugandan Women Living with HIV (2017) (1)
Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells (2020) (1)
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort (2022) (1)
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events (2022) (1)
Track A Basic Science (2012) (1)
Leaky gut, clotting, and vasculopathy in SIV. (2012) (1)
Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States (2022) (1)
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes (2013) (1)
Safety of Fecal Microbial Transplantation During Treated HIV Infection (2015) (1)
Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS (2021) (1)
Serum-derived bovine immunoglobulin isolate increases peripheral and mucosal CD4 T cell count in patients with HIV enteropathy (2015) (1)
Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection (2020) (1)
Class of antiretroviral drugs and anemia risk in the current treatment era (2019) (1)
Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4+ T Lymphocyte Depletion in Treated HIV Infection (2017) (1)
Reply to Cannizzo et al. (2015) (0)
Disease drivers of aging Which mechanisms do or do not drive aging in diabetics ? (2017) (0)
Decreased Telomerase Activity Is Associated with Reduced Diffusing Capacity (DLCO) in a Cohort of Persons Living with HIV (2019) (0)
Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART (2019) (0)
Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV (2023) (0)
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy. (2023) (0)
Associations Between Markers of Inflammation, Immune Activation, and Cellular Aging in Bronchoalveolar Lavage (BAL) Fluid and Lung Function in Persons Living with HIV (PLWH) (2021) (0)
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy (2019) (0)
Plasma interleukin-6 (IL-6), angiopoietin-2, and C-reactive protein levels predict subsequent type 1 myocardial infarction in persons with treated HIV infection. (2023) (0)
Associations of Inflammatory and Immune Activation Biomarkers and Lung Function in a Cohort of Persons Living with Human Immunodeficiency Virus (2020) (0)
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients. (2022) (0)
Serum-derived bovine immunoglobulin increases peripheral and mucosal CD4 T cell count (MUC8P.736) (2015) (0)
Enrolled in ACTG Studies (2012) (0)
Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention (2023) (0)
Correction to: Genetic architecture of cardiometabolic risks in people living with HIV (2021) (0)
Association between chronic hepatitis C virus infection and myocardial infarction in people living with HIV in the United States (2018) (0)
HIV pathogenesis and immunity (WS-074) Chairpersons: Yoshio Koyanagi, Guido Poli (2010) (0)
Ageing and HIV: From bench to clinic (2016) (0)
Subclinical cardiac disease in children with perinatally acquired HIV is associated with inflammation. (2022) (0)
Alcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation: The Uganda ARCH Cohort Study. (2021) (0)
Accumulation of HIV-1 Drug Resistance Mutations and Methamphetamine Use. (2021) (0)
TGF-β associated senescence and impaired metabolism in central memory CD4 T cells promotes HIV persistence (2021) (0)
CD8+ T-cell effector molecules are differentially expressed in blood and gastrointestinal mucosa in chronic HIV-1 infection (2018) (0)
Retina Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome (2018) (0)
Time : 11 : 00 AM – 11 : 15 AM Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome (2017) (0)
T cell immunosenescence is associated with the presence of Kaposi’s sarcoma in antiretroviral treated human immunodeficiency virus-infected persons (2010) (0)
Prevalence and determinants of Kaposi's sarcoma-associated herpesvirus (KSHV) antibody positivity among adults living with HIV in East Africa (2022) (0)
Chronic inflammation and its role in HIV pathogenesis (2014) (0)
Identification of human endogenous retrovirus (HERV-K(HML-2))-specific mucosal CD4+ T cell responses in HIV-1-exposed, seronegative individuals (P6195) (2013) (0)
Multiple substance use, inflammation and cardiac stretch in women living with HIV. (2022) (0)
Track B Clinical Science (2012) (0)
Distinct cellular immune signatures in acute Zika virus infection are associated with high or low persisting neutralizing antibody titers (2021) (0)
IL-15 drives CD8 T cell cycling and differentiation in chronic HIV-1 infection (VIR6P.1162) (2015) (0)
Association of age-related macular degeneration with mortality in patients with AIDS; role of systemic inflammation (2019) (0)
Isolated Low Diffusion Capacity Is Related to Increased Respiratory Symptom Burden in People with HIV (2021) (0)
Prevalence and Risk Factors for Intimate Partner Violence in Women Living with HIV in Uganda (2017) (0)
HIV & Hepatitis in the Americas 28–30 April 2016, Mexico City, Mexico (2016) (0)
Intact HIV genomes are enriched in memory T cells with short half-lives (2019) (0)
Association of Age-related Macular Degeneration with Retinal Vascular Caliber in Patients with the Acquired Immunodeficiency Syndrome (2018) (0)
Cooking Fuel Type and Respiratory Symptoms Among a Cohort of People Living With HIV in Rural Uganda (2015) (0)
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors (2022) (0)
Immune activation and risk of Hypertension in HIV-Infected Adults initiating antiretroviral therapy in Uganda: A nested case-control study (2015) (0)
Distribution and phenotype of HIV-specific CD8 T cells in situ in the rectal mucosa of HIV+ elite controllers (2017) (0)
M. tuberculosis antigen-responsive IL17+ CD4 T cells are disproportionately spared in ART-suppressed HIV (2023) (0)
Functionality of tissue-resident CD8+ T-cells in the human gastrointestinal tract during chronic HIV-1 infection. (2017) (0)
Efavirenz-metabolizing polymorphisms, viral suppression, and depression in HIV-infected individuals initiating antiretroviral therapy in southwestern Uganda (2017) (0)
Host variation in type I interferon signaling genes (MX1), CCR5Δ32, and MHC class I alleles in treated HIV+ non-controllers predict viral reservoir size (2022) (0)
Beyond undetectable: Modeling the clinical benefit of improved antiretroviral adherence in persons with HIV with virologic suppression (2023) (0)
MicroRNAs: novel tools to block gut inflammation in HIV? (2017) (0)
Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter W. Hunt?

Peter W. Hunt is affiliated with the following schools:

University of California, Berkeley
University of California, San Francisco

Peter W. Hunt's Academic­Influence.com Rankings